2000, Advocacy and Clinical Trials - Medical Cannabis Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2000

Advocacy

Clinical Trials

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

NOVEMBER 24, 2021

Using a content analysis approach, we investigated articles about medicinal cannabis from 2000 to the end of 2019 in the Medical Journal of Australia, Australian Doctor , Medical Observer , Australian Journal of General Practice , Australian Family Physicia n , and Australian Medicine. Data collection.

Research and Development

Research and Development Medicine Access Media

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009.

Research and Development

Research and Development Medicine Treatment Pharmaceutical

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Stay Connected